Paratek Pharmaceuticals, Inc.
PRTK · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $34 | $80 | $105 | $102 |
| Short-Term Investments | $0 | $15 | $20 | $113 |
| Receivables | $78 | $33 | $16 | $10 |
| Inventory | $17 | $11 | $15 | $12 |
| Other Curr. Assets | $8 | $12 | $9 | $7 |
| Total Curr. Assets | $137 | $152 | $164 | $243 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $4 |
| Goodwill | $1 | $1 | $1 | $1 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $32 | $28 | $9 | $3 |
| Total NC Assets | $36 | $32 | $13 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $173 | $184 | $177 | $251 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $2 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $32 | $26 | $22 | $20 |
| Total Curr. Liab. | $37 | $31 | $24 | $24 |
| LT Debt | $258 | $256 | $252 | $263 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $48 | $25 | $3 | $4 |
| Total NC Liab. | $306 | $280 | $255 | $267 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $344 | $312 | $279 | $291 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $706 | $672 |
| Retained Earnings | -$930 | -$867 | -$808 | -$711 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $759 | $739 | -$0 | -$0 |
| Total Equity | -$171 | -$128 | -$102 | -$40 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $173 | $184 | $177 | $251 |
| Net Debt | $224 | $175 | $147 | $161 |